Evidence-Based Clinical Practice Guideline for Attention Deficit Hyperactivity Disorder

Course overview

Course Description: This course is based on material published in the Australian and New Zealand Journal of Psychiatry and is available as an open-access article. The objective of this article was to provide an overview of the development and recommendations from the Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder (ADHD). The guideline aims to promote accurate and timely identification and diagnosis, and optimal and consistent treatment of ADHD. Development integrated the best available evidence with multidisciplinary clinical expertise and the preferences of those with lived experience, underpinned by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. The 23 guideline development group members included psychiatrists, pediatricians, general practitioners, psychologists, speech pathologists, occupational therapists, educators, Indigenous psychologists, and people with lived experience, with two independent chairs and a methodologist. Where appropriate, evidence reviews from the National Institute for Health and Care Excellence (NICE) 2018 Attention Deficit Hyperactivity Disorder: Diagnosis and Management guideline were updated. Fifty prioritized clinical questions were addressed in 14 systematic reviews (new and updated from NICE 2018) and 28 narrative reviews. The 113 clinical recommendations apply to young children (5 years and under), children, adolescents, and adults. They provide guidance for clinicians on identification, screening, diagnosis, multimodal treatment and support, including pharmacological and non-pharmacological interventions. The guidelines and supporting information are available online. The guideline was approved by the National Health and Medical Research Council (NHMRC) of Australia and relevant medical and allied health professional associations. It is anticipated that successful implementation and uptake of the guideline by organizations, health care providers, and other professionals will increase the delivery of evidence-based treatment and improve health outcomes for the more than 800,000 Australians with ADHD. This course on clinical practices for addressing attention deficit hyperactivity disorder is designed for clinical social workers, psychologists, professional counselors, nurses, and substance abuse counselors who do clinical work. It is appropriate for intermediate and advanced-level practitioners who wish to develop their expertise with clinical practices for addressing attention deficit hyperactivity disorder. The course material includes a literature review of interventions. It may also be useful for licensed clinicians who require continuing clinical education courses for license renewal. The course is based on a journal article that includes research. It contains statistical analysis and data that some clinicians enjoy reading, and others do not. A significant benefit of reading peer-reviewed research-based articles for continuing education is that they provide practitioners with the latest findings in their field. Authors: May, Birch, Chaves, Cranswick, Culnane, Delaney, Derrick, Eapen, Edlington, Efron, Ewais, Garner, Gathercole, Jagadheesan, Jobson, Kramer, Mack, Misso, Murrup-Stewart, Savage, Sciberras, Singh, Testa, Vale, Weirman, Petch, Williams, Bellgrove Learning Objectives: This course will provide the practitioner with detailed information regarding clinical practices for addressing attention deficit hyperactivity disorder. Specifically, a professional will: Describe characteristics of attention deficit hyperactivity disorder. Identify screening and identification recommendations for attention deficit hyperactivity disorder. Recognize strategies for managing attention deficit hyperactivity disorder. Citation: May, T., Birch, E., Chaves, K., Cranswick, N., Culnane, E., Delaney, J., Derrick, M., Eapen, V., Edlington, C., Efron, D., Ewais, T., Garner, I., Gathercole, M., Jagadh